Transcripts ARS Pharmaceuticals, Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 17/06/2024 BST			5-day change	1st Jan Change
8.41 ^USD	-2.89%		-7.28%	+53.47%

06-13	Ars Pharmaceuticals Insider Sold Shares Worth $913,917, According to a Recent SEC Filing	MT
05-09	ARS Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Transcript : ARS Pharmaceuticals, Inc., Silverback Therapeutics, Inc. - M&A Call	21/07/22
Transcript : Silverback Therapeutics, Inc. Presents at H.C. Wainwright BioConnect Conference, Jan-10-2022 07:00 AM	10/01/22
Transcript : Silverback Therapeutics, Inc. - Special Call	16/09/21

No results for this search